跳至主要内容
临床试验/NCT01895517
NCT01895517已完成4 期

Randomized Controlled Trial to Evaluate the Efficacy of Concurrent Liquid-based Cytology ( LBC) and HPV DNA Testing Versus LBC Alone for the Primary Cervical Cancer Screening

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan2 个研究点 分布在 1 个国家目标入组 18,471 人开始时间: 2013年6月7日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
18,471
试验地点
2
主要终点
The incidence of cervical intraepithelial neoplasia(CIN)3 or worse during the whole period

研究概览

简要总结

The aim of this study is to assess efficacy of the screening with concurrent liquid-based cytology and HPV DNA testing for the primary cervical cancer screening over 7 years.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
30 Years 至 64 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged 30-64 years old
  • Participants provided written informed consent

排除标准

  • will receive planed HPV DNA testing by local governmental cervical cancer program next six years
  • have had cervical invasive cancer before
  • have undergone cervical conization
  • have undergone hysterectomy
  • have had or have the cytological abnormalities and are under follow-up
  • are pregnant
  • are judged ineligible for this trial by physician

结局指标

主要结局

The incidence of cervical intraepithelial neoplasia(CIN)3 or worse during the whole period

时间窗: 6 years

次要结局

  • The incidence of CIN1 or worse at baseline, and two years, four years, and six years post baseline(2 years, 4 years, 6 years)
  • The incidence of CIN3 or worse at baseline, and two years, four years, and six years post baseline(2 years, 4 years, 6 years)
  • The incidence of CIN2 or worse at baseline, and two years, four years, and six years post baseline(2 years, 4 years, 6 years)
  • The incidence of invasive cancer at baseline, and two years, four years, and six years post baseline(2 years, 4 years, 6 years)
  • The number of colposcopy and biopsy performance(6 years)
  • The number of cervical cytology performance(6 years)

研究者

发起方
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验